淋病治療の世界市場：市場規模・現状・予測

• 英文タイトル：Global Gonorrhea Therapeutics Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9ST04172 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

※当調査レポートでは、淋病治療の世界市場について調査・分析し、淋病治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（単独療法、二重療法）、用途別（診療所、病院、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の淋病治療市場動向 ・主要企業別マーケットシェア ・淋病治療の種類別市場規模2014-2019 （単独療法、二重療法） ・淋病治療の用途別市場規模2014-2019 （診療所、病院、その他） ・淋病治療の北米市場：主要企業・種類別/用途別市場規模 ・淋病治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・淋病治療の中国市場：主要企業・種類別/用途別市場規模 ・淋病治療の日本国内市場：主要企業・種類別/用途別市場規模 ・淋病治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・淋病治療のインド市場：主要企業・種類別/用途別市場規模 ・淋病治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Bharat Pharmaceuticals、GlaxoSmithKline、Merck、Pfizer、Alopexx Pharmaceuticals、AstraZeneca、Debiopharm Group、Melinta Therapeutics） ・淋病治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ...

Gonorrhea is a sexually transmitted disease (STD) that affects both men and women. The infection affects the genitals, rectum, and the throat. The treatment landscape typically involves the use of antibiotics with dual therapy dominating the market compared with monotherapy. As the market has a deep penetration of generics, the growth rate is expected to be moderate during the forecast period. Additionally, the advent of new antibiotic-resistant strains will continue to hinder the growth prospects. The latest trend gaining momentum in the market is Advent of vaccine for prevention of gonorrhea. Gonorrhea is a major public health concern globally. It is considerably affecting the reproductive health of people and increasing the spread of human immunodeficiency virus (HIV). The currently available treatment regimen is unsuccessful in controlling the spread of Neisseria gonorrhoeae due to the rapid emergence of the antibiotic-resistant strains of this bacterium. Therefore, the prevention of the disease seems to be a more appropriate approach for controlling the spread of Neisseria gonorrhoeae.
One of the major drivers for this market is Rising prevalence of disease. The rising prevalence of gonorrhea is a major health concern globally. The disease follows chlamydial infection as the second most common STD in the US. The rising prevalence rate of gonorrhea is due to several factors such as growing awareness, increased healthcare access, availability of diagnostic tests, resistance patterns, reporting practices, and the financial constraints that limit the abilities of public healthcare officials to check the disease pattern precisely.
In 2018, the global Gonorrhea Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Gonorrhea Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gonorrhea Therapeutics development in United States, Europe and China.

The key players covered in this study
Bharat Pharmaceuticals
GlaxoSmithKline
Merck
Pfizer
Alopexx Pharmaceuticals
AstraZeneca
Debiopharm Group
Melinta Therapeutics

Market segment by Type, the product can be split into
Monotherapy
Dual Therapy

Market segment by Application, split into
Clinics
Hospitals
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Gonorrhea Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Gonorrhea Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Gonorrhea Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Gonorrhea Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Monotherapy
1.4.3 Dual Therapy
1.5 Market by Application
1.5.1 Global Gonorrhea Therapeutics Market Share by Application (2014-2025)
1.5.2 Clinics
1.5.3 Hospitals
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Gonorrhea Therapeutics Market Size
2.2 Gonorrhea Therapeutics Growth Trends by Regions
2.2.1 Gonorrhea Therapeutics Market Size by Regions (2014-2025)
2.2.2 Gonorrhea Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Gonorrhea Therapeutics Market Size by Manufacturers
3.1.1 Global Gonorrhea Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Gonorrhea Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Gonorrhea Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Gonorrhea Therapeutics Key Players Head office and Area Served
3.3 Key Players Gonorrhea Therapeutics Product/Solution/Service
3.4 Date of Enter into Gonorrhea Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Gonorrhea Therapeutics Market Size by Type (2014-2019)
4.2 Global Gonorrhea Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Gonorrhea Therapeutics Market Size (2014-2019)
5.2 Gonorrhea Therapeutics Key Players in United States
5.3 United States Gonorrhea Therapeutics Market Size by Type
5.4 United States Gonorrhea Therapeutics Market Size by Application

6 Europe
6.1 Europe Gonorrhea Therapeutics Market Size (2014-2019)
6.2 Gonorrhea Therapeutics Key Players in Europe
6.3 Europe Gonorrhea Therapeutics Market Size by Type
6.4 Europe Gonorrhea Therapeutics Market Size by Application

7 China
7.1 China Gonorrhea Therapeutics Market Size (2014-2019)
7.2 Gonorrhea Therapeutics Key Players in China
7.3 China Gonorrhea Therapeutics Market Size by Type
7.4 China Gonorrhea Therapeutics Market Size by Application

8 Japan
8.1 Japan Gonorrhea Therapeutics Market Size (2014-2019)
8.2 Gonorrhea Therapeutics Key Players in Japan
8.3 Japan Gonorrhea Therapeutics Market Size by Type
8.4 Japan Gonorrhea Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Gonorrhea Therapeutics Market Size (2014-2019)
9.2 Gonorrhea Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Gonorrhea Therapeutics Market Size by Type
9.4 Southeast Asia Gonorrhea Therapeutics Market Size by Application

10 India
10.1 India Gonorrhea Therapeutics Market Size (2014-2019)
10.2 Gonorrhea Therapeutics Key Players in India
10.3 India Gonorrhea Therapeutics Market Size by Type
10.4 India Gonorrhea Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Gonorrhea Therapeutics Market Size (2014-2019)
11.2 Gonorrhea Therapeutics Key Players in Central & South America
11.3 Central & South America Gonorrhea Therapeutics Market Size by Type
11.4 Central & South America Gonorrhea Therapeutics Market Size by Application

12 International Players Profiles
12.1 Bharat Pharmaceuticals
12.1.1 Bharat Pharmaceuticals Company Details
12.1.2 Company Description and Business Overview
12.1.3 Gonorrhea Therapeutics Introduction
12.1.4 Bharat Pharmaceuticals Revenue in Gonorrhea Therapeutics Business (2014-2019)
12.1.5 Bharat Pharmaceuticals Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Company Details
12.2.2 Company Description and Business Overview
12.2.3 Gonorrhea Therapeutics Introduction
12.2.4 GlaxoSmithKline Revenue in Gonorrhea Therapeutics Business (2014-2019)
12.2.5 GlaxoSmithKline Recent Development
12.3 Merck
12.3.1 Merck Company Details
12.3.2 Company Description and Business Overview
12.3.3 Gonorrhea Therapeutics Introduction
12.3.4 Merck Revenue in Gonorrhea Therapeutics Business (2014-2019)
12.3.5 Merck Recent Development
12.4 Pfizer
12.4.1 Pfizer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Gonorrhea Therapeutics Introduction
12.4.4 Pfizer Revenue in Gonorrhea Therapeutics Business (2014-2019)
12.4.5 Pfizer Recent Development
12.5 Alopexx Pharmaceuticals
12.5.1 Alopexx Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Gonorrhea Therapeutics Introduction
12.5.4 Alopexx Pharmaceuticals Revenue in Gonorrhea Therapeutics Business (2014-2019)
12.5.5 Alopexx Pharmaceuticals Recent Development
12.6 AstraZeneca
12.6.1 AstraZeneca Company Details
12.6.2 Company Description and Business Overview
12.6.3 Gonorrhea Therapeutics Introduction
12.6.4 AstraZeneca Revenue in Gonorrhea Therapeutics Business (2014-2019)
12.6.5 AstraZeneca Recent Development
12.7 Debiopharm Group
12.7.1 Debiopharm Group Company Details
12.7.2 Company Description and Business Overview
12.7.3 Gonorrhea Therapeutics Introduction
12.7.4 Debiopharm Group Revenue in Gonorrhea Therapeutics Business (2014-2019)
12.7.5 Debiopharm Group Recent Development
12.8 Melinta Therapeutics
12.8.1 Melinta Therapeutics Company Details
12.8.2 Company Description and Business Overview
12.8.3 Gonorrhea Therapeutics Introduction
12.8.4 Melinta Therapeutics Revenue in Gonorrhea Therapeutics Business (2014-2019)
12.8.5 Melinta Therapeutics Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Gonorrhea Therapeutics Key Market Segments
Table Key Players Gonorrhea Therapeutics Covered
Table Global Gonorrhea Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Gonorrhea Therapeutics Market Size Market Share by Type 2014-2025
Figure Monotherapy Figures
Table Key Players of Monotherapy
Figure Dual Therapy Figures
Table Key Players of Dual Therapy
Table Global Gonorrhea Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Clinics Case Studies
Figure Hospitals Case Studies
Figure Others Case Studies
Figure Gonorrhea Therapeutics Report Years Considered
Table Global Gonorrhea Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Gonorrhea Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Gonorrhea Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Gonorrhea Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Gonorrhea Therapeutics Market Share by Regions 2014-2019
Figure Global Gonorrhea Therapeutics Market Share by Regions 2014-2019
Figure Global Gonorrhea Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Gonorrhea Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Gonorrhea Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Gonorrhea Therapeutics Market Share by Manufacturers in 2018
Table Global Gonorrhea Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Gonorrhea Therapeutics Product/Solution/Service
Table Date of Enter into Gonorrhea Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Gonorrhea Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Gonorrhea Therapeutics Market Size Share by Type (2014-2019)
Figure Global Gonorrhea Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Gonorrhea Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Gonorrhea Therapeutics Market Size Share by Application (2014-2019)
Figure Global Gonorrhea Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Gonorrhea Therapeutics Revenue Market Share by Application in 2018
Figure United States Gonorrhea Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Gonorrhea Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Gonorrhea Therapeutics Market Share (2018-2019)
Table United States Gonorrhea Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Gonorrhea Therapeutics Market Share by Type (2014-2019)
Table United States Gonorrhea Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Gonorrhea Therapeutics Market Share by Application (2014-2019)
Figure Europe Gonorrhea Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Gonorrhea Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Gonorrhea Therapeutics Market Share (2018-2019)
Table Europe Gonorrhea Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Gonorrhea Therapeutics Market Share by Type (2014-2019)
Table Europe Gonorrhea Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Gonorrhea Therapeutics Market Share by Application (2014-2019)
Figure China Gonorrhea Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Gonorrhea Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Gonorrhea Therapeutics Market Share (2018-2019)
Table China Gonorrhea Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Gonorrhea Therapeutics Market Share by Type (2014-2019)
Table China Gonorrhea Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Gonorrhea Therapeutics Market Share by Application (2014-2019)
Figure Japan Gonorrhea Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Gonorrhea Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Gonorrhea Therapeutics Market Share (2018-2019)
Table Japan Gonorrhea Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Gonorrhea Therapeutics Market Share by Type (2014-2019)
Table Japan Gonorrhea Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Gonorrhea Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Gonorrhea Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Gonorrhea Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Gonorrhea Therapeutics Market Share (2018-2019)
Table Southeast Asia Gonorrhea Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Gonorrhea Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Gonorrhea Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Gonorrhea Therapeutics Market Share by Application (2014-2019)
Figure India Gonorrhea Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Gonorrhea Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Gonorrhea Therapeutics Market Share (2018-2019)
Table India Gonorrhea Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Gonorrhea Therapeutics Market Share by Type (2014-2019)
Table India Gonorrhea Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Gonorrhea Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Gonorrhea Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Gonorrhea Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Gonorrhea Therapeutics Market Share (2018-2019)
Table Central & South America Gonorrhea Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Gonorrhea Therapeutics Market Share by Type (2014-2019)
Table Central & South America Gonorrhea Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Gonorrhea Therapeutics Market Share by Application (2014-2019)
Table Bharat Pharmaceuticals Company Details
Table Bharat Pharmaceuticals Revenue in Gonorrhea Therapeutics Business (2014-2019) (Million US$)
Figure Bharat Pharmaceuticals Revenue Growth Rate in Gonorrhea Therapeutics Business (2014-2019)
Table Bharat Pharmaceuticals Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Gonorrhea Therapeutics Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Gonorrhea Therapeutics Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Merck Company Details
Table Merck Revenue in Gonorrhea Therapeutics Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Gonorrhea Therapeutics Business (2014-2019)
Table Merck Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Gonorrhea Therapeutics Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Gonorrhea Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table Alopexx Pharmaceuticals Company Details
Table Alopexx Pharmaceuticals Revenue in Gonorrhea Therapeutics Business (2014-2019)(Million US$)
Figure Alopexx Pharmaceuticals Revenue Growth Rate in Gonorrhea Therapeutics Business (2014-2019)
Table Alopexx Pharmaceuticals Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Gonorrhea Therapeutics Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Gonorrhea Therapeutics Business (2014-2019)
Table AstraZeneca Recent Development
Table Debiopharm Group Company Details
Table Debiopharm Group Revenue in Gonorrhea Therapeutics Business (2014-2019)(Million US$)
Figure Debiopharm Group Revenue Growth Rate in Gonorrhea Therapeutics Business (2014-2019)
Table Debiopharm Group Recent Development
Table Melinta Therapeutics Company Details
Table Melinta Therapeutics Revenue in Gonorrhea Therapeutics Business (2014-2019)(Million US$)
Figure Melinta Therapeutics Revenue Growth Rate in Gonorrhea Therapeutics Business (2014-2019)
Table Melinta Therapeutics Recent Development
Table Global Gonorrhea Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Gonorrhea Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Gonorrhea Therapeutics Market Size Share by Regions in 2025
Figure United States Gonorrhea Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Gonorrhea Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Gonorrhea Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Gonorrhea Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Gonorrhea Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Gonorrhea Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Gonorrhea Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Gonorrhea Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Gonorrhea Therapeutics Market Size by Product (2019-2025)
Figure Global Gonorrhea Therapeutics Market Size by Product in 2025
Table Global Gonorrhea Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Gonorrhea Therapeutics Market Size by Application (2019-2025)
Figure Global Gonorrhea Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---